Tirzepatide is a novel dual agonist targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This synthetic peptide represents a significant advancement in diabetes research, combining two important insulinotropic mechanisms in a single molecule.
With a molecular weight of 4813 and CAS number 2023788-19-2, our Tirzepatide offers exceptional purity (99.9%) for research applications. The product is supplied in convenient 10mg/vial packaging, with 10 vials per kit, making it ideal for laboratory use.
Research indicates that Tirzepatide demonstrates promising effects on glycemic control through its unique mechanism of action. By simultaneously activating both GIP and GLP-1 receptors, it enhances glucose-dependent insulin secretion while suppressing glucagon secretion.
Our competitive Tirzepatide UK price makes this innovative compound accessible for research institutions and pharmaceutical developers. The product is synthesized under strict quality controls to ensure consistency and reliability for scientific studies.
Please note: This product is intended for research purposes only and not for human consumption. All transactions are subject to verification of intended research use.